What is the prevalence of Fibromuscular dysplasia?

The exact prevalence of Fibromuscular dysplasia remains unknown due to frequent underdiagnosis, though estimates suggest it affects between 0.3% and 3% of the general population. While Fibromuscular dysplasia is classified as a rare disease, it is significantly more common in females than in males and is most frequently diagnosed in adults between the ages of 40 and 60.

How common is Fibromuscular dysplasia?

Determining the true prevalence of Fibromuscular dysplasia is challenging because many individuals remain asymptomatic and never undergo the vascular imaging required for a diagnosis. While some older studies suggested it was quite rare, modern imaging techniques and increased clinical awareness have revealed that Fibromuscular dysplasia is likely much more prevalent than once thought. Currently, there is no precise global registry to track every case, but the condition is widely recognized by medical experts as an underdiagnosed cause of secondary hypertension and vascular abnormalities.

Who is most affected by Fibromuscular dysplasia?

Epidemiological data consistently shows a strong gender bias, with approximately 90% of identified Fibromuscular dysplasia patients being female. While the condition can occur in children and teenagers, it is primarily an adult-onset disease, with the most common age of diagnosis falling between 40 and 60 years. Although it can affect any ethnic group, current clinical literature does not suggest significant geographic or ethnic variations in the prevalence of the disease, though research remains ongoing to determine if genetic predispositions vary across populations.

Why is accurate data on Fibromuscular dysplasia difficult to obtain?

The challenges in establishing accurate statistics for Fibromuscular dysplasia include:

• Asymptomatic presentation: Many individuals live their entire lives without symptoms, meaning they are never included in clinical databases.


• Diagnostic hurdles: The condition often mimics other vascular diseases, leading to misdiagnosis or delayed identification.


• Imaging limitations: Diagnosis requires specific vascular imaging (such as CT angiography or MR angiography), which is not performed on the general population.


• Community perspective: At DiseaseMaps.org, 132 people with Fibromuscular dysplasia have joined the community to share their experiences, providing a crucial, real-world supplement to clinical data that helps researchers understand the patient journey beyond standard hospital statistics.

Is Fibromuscular dysplasia considered rare?

In most clinical contexts, Fibromuscular dysplasia is categorized as a rare disease. However, because it is increasingly identified in patients undergoing imaging for unrelated conditions, some experts argue it should be considered an "underdiagnosed" condition rather than an ultra-rare one. Because the prevalence estimates vary widely based on the population studied—ranging from a fraction of a percent to as high as 3% in specific hypertension cohorts—it is essential to interpret these numbers as estimates rather than absolute population counts.

Next steps

• Consult a vascular specialist, cardiologist, or nephrologist if you have unexplained high blood pressure or vascular symptoms.


• Request a referral for specialized vascular imaging (CTA or MRA) if your physician suspects non-atherosclerotic vascular disease.


• Join the DiseaseMaps.org community to connect with other patients and share your experiences with Fibromuscular dysplasia.


• Stay informed through official patient advocacy groups like the FMDSA (Fibromuscular Dysplasia Society of America) for the latest clinical trial information.

Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Fibromuscular dysplasia overview.


• Orphanet: Rare disease database entry for Fibromuscular dysplasia (ORPHA:3335).


• Fibromuscular Dysplasia Society of America (FMDSA): Clinical research and patient data resources.


• PubMed/NCBI: "Prevalence and clinical characteristics of Fibromuscular dysplasia in the modern era."